Studies in mouse tumor xenografts of HSC3 cells have demonstrated that EGFR ligands are present in picomolar concentrations (<1–2 ng/ml) in vivo and that these concentrations are sufficient for tumor progression (Ohnishi et al., 2008; Pinilla-Macua et al., 2017). The gene discussed is EGFR; the disease is neoplasm.